166 related articles for article (PubMed ID: 2140509)
1. Tumor suppressor genes.
Levine AJ
Bioessays; 1990 Feb; 12(2):60-6. PubMed ID: 2140509
[TBL] [Abstract][Full Text] [Related]
2. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the p53 gene occur in diverse human tumour types.
Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
[TBL] [Abstract][Full Text] [Related]
5. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
Chang F; Syrjänen S; Kurvinen K; Syrjänen K
Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
[TBL] [Abstract][Full Text] [Related]
6. The nuclear oncoproteins: RB and p53.
Cowell JK
Semin Cancer Biol; 1990 Dec; 1(6):437-46. PubMed ID: 2151736
[TBL] [Abstract][Full Text] [Related]
7. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
Wiman KG
Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
9. The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53.
Levine AJ
Virology; 2009 Feb; 384(2):285-93. PubMed ID: 19081592
[TBL] [Abstract][Full Text] [Related]
10. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.
Takahashi T; D'Amico D; Chiba I; Buchhagen DL; Minna JD
J Clin Invest; 1990 Jul; 86(1):363-9. PubMed ID: 2164047
[TBL] [Abstract][Full Text] [Related]
11. Oncosuppressor genes: mechanisms of inactivation for the retinoblastoma gene and p53.
Clerico L; Mancuso T; Noonan D; Albini A
Boll Soc Ital Biol Sper; 1993 Dec; 69(12):725-34. PubMed ID: 8003286
[TBL] [Abstract][Full Text] [Related]
12. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
13. The molecular genetics of retinoblastoma.
Goodrich DW; Lee WH
Cancer Surv; 1990; 9(3):529-54. PubMed ID: 2101724
[TBL] [Abstract][Full Text] [Related]
14. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
Romano JW; Ehrhart JC; Duthu A; Kim CM; Appella E; May P
Oncogene; 1989 Dec; 4(12):1483-8. PubMed ID: 2531855
[TBL] [Abstract][Full Text] [Related]
16. The Pezcoller lecture: cancer cell cycles revisited.
Sherr CJ
Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
[TBL] [Abstract][Full Text] [Related]
17. [Dominant negative activity of mutated p53 proteins].
Dridi W; Krabchi K; Gadji M; Lavoie J; Bronsard M; Fetni R; Drouin R
Med Sci (Paris); 2006 Mar; 22(3):301-7. PubMed ID: 16527213
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
19. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas.
Shew JY; Ling N; Yang XM; Fodstad O; Lee WH
Oncogene Res; 1989; 4(3):205-14. PubMed ID: 2740144
[TBL] [Abstract][Full Text] [Related]
20. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
